| T Lymphoblastic Leukemia/Lymphoma studied in …STUDIED_INderived140 of 140show fewer |
|---|
| → studied in | NCT06738368Phase 2 · suspended Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06514794Phase 2 · recruiting A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06561074Phase 2 · recruiting A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05289687Phase 2 · recruiting Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04128501Phase 2 · active not recruiting Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04972942Phase 1 · recruiting Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04315324Phase 1/Phase 2 · active not recruiting Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06648889Phase 2 · recruiting Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00792948Phase 2 · active not recruiting Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04033302Phase 1/Phase 2 · not yet recruiting Multi-CAR T Cell Therapy Targeting CD7-positive Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05995028Phase 1 · not yet recruiting Universal 4SCAR7U Targeting CD7-positive Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07784309Phase 1 · enrolling by invitation A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05277753Phase 1 · terminated NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05602194Phase 3 · active not recruiting Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007147Phase 3 · active not recruiting Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07774377Phase 3 · not yet recruiting Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07513129Phase 1 · recruiting Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03081910Phase 1 · recruiting Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06390319Phase 2 · recruiting Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03504644Phase 1/Phase 2 · active not recruiting Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072585Phase 2/Phase 3 · not yet recruiting Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02112916Phase 3 · active not recruiting Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00501826Phase 2 · recruiting Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07678307Phase 1/Phase 2 · not yet recruiting A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408005Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03690011Phase 1 · active not recruiting Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07636564Phase 2 · not yet recruiting Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04318678Phase 1 · recruiting CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07220993Phase 1 · recruiting Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07585734Phase 1/Phase 2 · withdrawn Clinical Trial of CD38 Monoclonal Antibody Combined With Chemotherapy for T-Cell Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03808610Phase 1/Phase 2 · terminated Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06874946Phase 1/Phase 2 · recruiting Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07541755Phase 3 · active not recruiting PD-1 Inhibitors +Venetoclax+CAG Regimens in R/R T-ALL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07523555Phase 1/Phase 2 · recruiting Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05376111Phase 2 · recruiting Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05909527Phase 1/Phase 2 · withdrawn A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07476027early Phase 1 · not yet recruiting Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05679895Phase 1 · recruiting Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06316856Phase 1/Phase 2 · recruiting CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253637Phase 2 · active not recruiting Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05170828Phase 1 · withdrawn Cryopreserved MMUD BM With PTCy for Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712121Phase 2 · recruiting Venetoclax and Decitabine in R/R T-ALL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04681105Phase 1 · completed Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07300683Phase 1 · recruiting Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07153068Phase 1/Phase 2 · recruiting SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05991973Phase 2 · completed Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06316427Phase 1/Phase 2 · recruiting Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07070323Phase 1/Phase 2 · recruiting A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07244380Phase 2 · not yet recruiting Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL. · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01139970Phase 1 · completed Veliparib and Temozolomide in Treating Patients With Acute Leukemia · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04984356Phase 1 · completed A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02512497Phase 1 · completed Romidepsin Maintenance After Allogeneic Stem Cell Transplantation · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109518Phase 1 · recruiting uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05032183Phase 1/Phase 2 · terminated Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021677Phase 2 · recruiting Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia" · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012447Phase 2 · recruiting Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Early T Precursor Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05290155Phase 1 · completed Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04689659Phase 2 · completed Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06849401early Phase 1 · not yet recruiting The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05149378Phase 2 · completed Venetoclax Based Regimen for R/R T-ALL · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038644Phase 1 · terminated XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06686108Phase 2 · recruiting Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06462365Phase 1 · recruiting Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02484430Phase 2 · completed Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06361329Phase 3 · recruiting Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | Early T Precursor Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05885464Phase 1/Phase 2 · active not recruiting A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06741813NA · not yet recruiting Allo-HSCT vs ASCT in Adult T-LBL · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05509855enrolling by invitation A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007 · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05032599Phase 1 · terminated Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06420076Phase 1/Phase 2 · recruiting Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06633341early Phase 1 · recruiting Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06633354early Phase 1 · recruiting Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06598722Phase 2 · recruiting BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma. · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00557193Phase 3 · completed Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06434467Phase 3 · unknown The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06210750Phase 2 · withdrawn Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06381817Phase 3 · recruiting Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06376721Phase 1/Phase 2 · recruiting Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168140Phase 1 · completed CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04582487NA · unknown Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422679Phase 1/Phase 2 · terminated Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04828174Phase 1 · suspended Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06136364Phase 1 · recruiting CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02763384Phase 2 · terminated BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05320380Phase 1/Phase 2 · withdrawn A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05519527Phase 1 · withdrawn STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05576532Phase 2 · unknown Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05832125unknown Registry of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01028716Phase 2 · terminated Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04860817early Phase 1 · withdrawn A Study of Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05620680NA · recruiting CD7 CAR-T Cells in T-cell Lymphoma/Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05596266Phase 1 · unknown CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00684619Phase 2 · completed 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05398614Phase 1 · unknown SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061945Phase 1/Phase 2 · completed Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03519984Phase 1 · terminated EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05127135Phase 1 · unknown Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00412360Phase 3 · completed Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Natural Killer Cell Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04934774Phase 1 · unknown Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04762485Phase 1/Phase 2 · unknown Humanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04785833NA · unknown CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04594135Phase 1 · unknown Anti-CD5 CAR T Cells for Relapsed/Refractory T Cell Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04480788Phase 1 · unknown CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label Study · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04679506unknown the Efficacy and Safety of CLAE in R/R T-ALL/LBL · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04620655NA · unknown RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01258998Phase 2 · completed Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483690Phase 1/Phase 2 · terminated A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981799Phase 1/Phase 2 · terminated Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04004637Phase 1 · unknown CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02767934Phase 2 · terminated Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04446130Phase 3 · unknown Study of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers Patients · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04437420unknown Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90 · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918333Phase 1/Phase 2 · completed Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02228772Phase 1 · completed Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02652715NA · completed Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02619630Phase 2 · unknown Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old) · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02518113Phase 1/Phase 2 · completed A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00382109Phase 3 · completed Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01363817Phase 1 · completed Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02538926Phase 2 · withdrawn Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Lymphoblastic Leukemia/Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03558412Phase 4 · unknown A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | T Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03613428Phase 1/Phase 2 · unknown Ruxolitinib Plus LVP in Patients With R/R ETP-ALL · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01567709Phase 1 · completed Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00437060completed Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052520Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873093Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742727Phase 1/Phase 2 · unknown CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898404completed Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337595Phase 1/Phase 2 · completed Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01403415Phase 1 · completed Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00608361Phase 1 · completed Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery · condition mapped ONTOLOGY_EXACT · 140 trials mapped (58 active) | — | — | Adult T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01088763Phase 1 · terminated Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101205Phase 1 · terminated Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049569NA · completed Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00301938Phase 1 · completed 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01950286completed Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden. · condition mapped CURATED_BROADER · 140 trials mapped (58 active) | — | — | T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002970Phase 2 · completed 506U78 in Treating Patients With Refractory Hematologic Cancer · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016302NA · completed Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · condition mapped ALIAS · 140 trials mapped (58 active) | — | — | Childhood T Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |